Pavel Klein

Mid-Atlantic Epilepsy and Sleep Center (MAESC) is a specialized medical facility and clinical research organization based in Bethesda, Maryland, dedicated to the diagnosis and treatment of epilepsy and sleep disorders. Founded and directed by Dr. Pavel Klein in 2001, the center serves as a premier site for Phase I through Phase IV clinical trials, evaluating novel anti-seizure medications and sleep therapies. MAESC provides comprehensive neurological care, including advanced long-term video-EEG monitoring and polysomnography, to a large patient population. The center collaborates extensively with global pharmaceutical and biotechnology companies, contributing significantly to the clinical development of numerous FDA-approved neurological treatments. It is recognized for its expertise in managing complex, refractory epilepsy cases and its active role in academic neurological research.